Matches in SemOpenAlex for { <https://semopenalex.org/work/W3017098321> ?p ?o ?g. }
- W3017098321 endingPage "4159" @default.
- W3017098321 startingPage "4148" @default.
- W3017098321 abstract "The least toxic time (LTT) of irinotecan varied by up to 8 hours according to sex and genetic background in mice. The translational relevance was investigated within a randomized trial dataset, where no LTT stood out significantly in the whole population. 130 male and 63 female eligible patients with metastatic colorectal cancer were randomized to receive chronomodulated Irinotecan with peak delivery rate at 1 of 6 clock hours staggered by 4 hours on day 1, then fixed-time chronomodulated Fluorouracil-Leucovorin-Oxaliplatin for 4 days, q3 weeks. The sex-specific circadian characteristics of grade (G) 3-4 toxicities were mapped with cosinor and time*sex interactions confirmed with Fisher's exact test. Baseline characteristics of male or female patients were similar in the six treatment groups. Main grade 3-4 toxicities over six courses were diarrhea (males vs females, 39.2%; vs 46.0%), neutropenia (15.6% vs 15.0%), fatigue (11.5% vs 15.9%), and anorexia (10.0% vs 7.8%). They were reduced following irinotecan peak delivery in the morning for males, but in the afternoon for females, with statistically significant rhythms (P < .05 from cosinor) and sex*timing interactions (Fisher's exact test, diarrhea, P = .023; neutropenia, P = .015; fatigue, P = .062; anorexia, P = .032). Irinotecan timing was most critical for females, with grades 3-4 ranging from 55.2% of the patients (morning) to 29.4% (afternoon) for diarrhea, and from 25.9% (morning) to 0% (afternoon) for neutropenia. The study results support irinotecan administration in the morning for males and in the afternoon for females, in order to minimize adverse events without impairing efficacy." @default.
- W3017098321 created "2020-04-24" @default.
- W3017098321 creator A5000057889 @default.
- W3017098321 creator A5000726989 @default.
- W3017098321 creator A5012325306 @default.
- W3017098321 creator A5018124634 @default.
- W3017098321 creator A5019631884 @default.
- W3017098321 creator A5022909423 @default.
- W3017098321 creator A5037937397 @default.
- W3017098321 creator A5060428508 @default.
- W3017098321 creator A5065770398 @default.
- W3017098321 creator A5072502548 @default.
- W3017098321 creator A5078259466 @default.
- W3017098321 date "2020-04-22" @default.
- W3017098321 modified "2023-10-18" @default.
- W3017098321 title "Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial" @default.
- W3017098321 cites W1545480108 @default.
- W3017098321 cites W1858949386 @default.
- W3017098321 cites W1971653103 @default.
- W3017098321 cites W1975787992 @default.
- W3017098321 cites W1976604498 @default.
- W3017098321 cites W1981565538 @default.
- W3017098321 cites W2004182744 @default.
- W3017098321 cites W2008600980 @default.
- W3017098321 cites W2019607817 @default.
- W3017098321 cites W2034585240 @default.
- W3017098321 cites W2041385613 @default.
- W3017098321 cites W2059748915 @default.
- W3017098321 cites W2074706593 @default.
- W3017098321 cites W2076423158 @default.
- W3017098321 cites W2086063692 @default.
- W3017098321 cites W2087544775 @default.
- W3017098321 cites W2089689504 @default.
- W3017098321 cites W2091289833 @default.
- W3017098321 cites W2095034757 @default.
- W3017098321 cites W2098064548 @default.
- W3017098321 cites W2098342740 @default.
- W3017098321 cites W2108585052 @default.
- W3017098321 cites W2128643078 @default.
- W3017098321 cites W2137900825 @default.
- W3017098321 cites W2151253787 @default.
- W3017098321 cites W2152208758 @default.
- W3017098321 cites W2166513300 @default.
- W3017098321 cites W2171235746 @default.
- W3017098321 cites W2327230031 @default.
- W3017098321 cites W2333798941 @default.
- W3017098321 cites W2551087603 @default.
- W3017098321 cites W2749779586 @default.
- W3017098321 cites W2788274788 @default.
- W3017098321 cites W2884878742 @default.
- W3017098321 cites W2887541522 @default.
- W3017098321 cites W2903623792 @default.
- W3017098321 cites W2943470918 @default.
- W3017098321 cites W2965281435 @default.
- W3017098321 cites W2967786139 @default.
- W3017098321 cites W2969513967 @default.
- W3017098321 cites W2980659545 @default.
- W3017098321 cites W4211057115 @default.
- W3017098321 cites W4292528167 @default.
- W3017098321 doi "https://doi.org/10.1002/cam4.3056" @default.
- W3017098321 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7300418" @default.
- W3017098321 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32319740" @default.
- W3017098321 hasPublicationYear "2020" @default.
- W3017098321 type Work @default.
- W3017098321 sameAs 3017098321 @default.
- W3017098321 citedByCount "37" @default.
- W3017098321 countsByYear W30170983212020 @default.
- W3017098321 countsByYear W30170983212021 @default.
- W3017098321 countsByYear W30170983212022 @default.
- W3017098321 countsByYear W30170983212023 @default.
- W3017098321 crossrefType "journal-article" @default.
- W3017098321 hasAuthorship W3017098321A5000057889 @default.
- W3017098321 hasAuthorship W3017098321A5000726989 @default.
- W3017098321 hasAuthorship W3017098321A5012325306 @default.
- W3017098321 hasAuthorship W3017098321A5018124634 @default.
- W3017098321 hasAuthorship W3017098321A5019631884 @default.
- W3017098321 hasAuthorship W3017098321A5022909423 @default.
- W3017098321 hasAuthorship W3017098321A5037937397 @default.
- W3017098321 hasAuthorship W3017098321A5060428508 @default.
- W3017098321 hasAuthorship W3017098321A5065770398 @default.
- W3017098321 hasAuthorship W3017098321A5072502548 @default.
- W3017098321 hasAuthorship W3017098321A5078259466 @default.
- W3017098321 hasBestOaLocation W30170983211 @default.
- W3017098321 hasConcept C121608353 @default.
- W3017098321 hasConcept C126322002 @default.
- W3017098321 hasConcept C143998085 @default.
- W3017098321 hasConcept C168563851 @default.
- W3017098321 hasConcept C19720800 @default.
- W3017098321 hasConcept C2776694085 @default.
- W3017098321 hasConcept C2777063308 @default.
- W3017098321 hasConcept C2779802037 @default.
- W3017098321 hasConcept C2780259306 @default.
- W3017098321 hasConcept C2908647359 @default.
- W3017098321 hasConcept C526805850 @default.
- W3017098321 hasConcept C71924100 @default.
- W3017098321 hasConcept C99454951 @default.
- W3017098321 hasConceptScore W3017098321C121608353 @default.
- W3017098321 hasConceptScore W3017098321C126322002 @default.